A flu outbreak at the University of Michigan is suggestive of a bad flu season and the current circulating strain, H3N2, often leads to higher rates of hospitalization and death.
The last season where H3N2 was the dominant strain was in 2017, when the U.S. had the worst and longest season since the 2009 H1N1 flu pandemic. Multiplex testing will be essential this season for the differential diagnosis of COVID and the flu, learn more about Meridian’s reagent solutions for both immuno and molecular multiplex assays.
![]()
Saliva/Sputum Specific RT-qPCR Mix
Air-Dryable Direct RNA/DNA qPCR Saliva
A glycerol-free mix designed for the direct detection of DNA and RNA from saliva (no extraction for RNA/DNA needed). Contains excipients compatible with oven drying.
|
|
Read more about COVID/Flu/RSV Multiplexing
Download the new whitepaper to learn about the benefits of multiplex testing for the differential diagnosis of COVID-19, flu, and RSV.
Meridian is expanding its market-leading specimen-specific molecular product line with the new Lyo-Ready™ Direct DNA/RNA qPCR Saliva master mixes! These mixes are capable of sensitive detection of DNA or RNA from unprocessed saliva samples. They are glycerol-free, 4x concentrated and contain an optimized blend of excipients that are compatible with lyophilization to easily create ambient-temperature stable assays! Never extract again!
Product Highlights:
- Simple and easy to use, all components are included – just add primers/probes
- Suitable for direct detection of very low titers of RNA or DNA in singleplex or multiplex assays using saliva or sputum samples
- Mixes can be used in a liquid or dry format, reducing the cost and complexity of developing an ambient-temperature stable assay
- Compatible with a range of lyophilization protocols
Product | Cat. No. | Volume | Reactions |
---|---|---|---|
Lyo-Ready™ Direct DNA qPCR Saliva | MDX132 | 5 ml | 1,000 Rxn |
50 mL | 10,000 Rxn | ||
Lyo-Ready™ Direct RNA/DNA qPCR Saliva | MDX1333 | 5 ml | 1,000 Rxn |
50 mL | 10,000 Rxn |